Your session is about to expire
← Back to Search
Cross-Training Program for Cancer Survivors (CAPABLE Trial)
N/A
Recruiting
Led By Jennifer Beebe-Dimmer, MPH, PhD.
Research Sponsored by Barbara Ann Karmanos Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosed with an invasive cancer
Aged 18 years or older at time of program recruitment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will see if cancer survivors who do a cross-training program improve more in functional performance, body composition, and quality of life compared to those who follow the American Cancer Society guidelines.
Who is the study for?
This trial is for cancer survivors who are 18 or older and have been diagnosed with invasive cancer. They must be cleared by their doctor to join the program, which could include those currently in treatment or those who've finished. Participants need a way to get to the facility on session days.
What is being tested?
The study tests a 12-week cross-training program against current American Cancer Society guidelines for cancer survivors. It aims to see if this new approach can better improve functional performance, body composition, and quality of life.
What are the potential side effects?
Since this is an exercise-based intervention rather than medication, side effects may include muscle soreness, fatigue, and potential injury from physical activity. The intensity will be tailored to each participant's ability.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with a cancer that is spreading into surrounding tissues.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Body Composition
Change in Motivation
Change in functional performance and variability in functional performance among adult cancer survivors enrolled in a high-intensity functional training program
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: A 12-week pilot intervention study introducing a high-intensiExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Barbara Ann Karmanos Cancer InstituteLead Sponsor
164 Previous Clinical Trials
9,148 Total Patients Enrolled
Jennifer Beebe-Dimmer, MPH, PhD.Principal Investigator - Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a way to get to and from the clinic on my appointment days.I have been diagnosed with a cancer that is spreading into surrounding tissues.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: A 12-week pilot intervention study introducing a high-intensi
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.